Hepatitis Monthly

Published by: Kowsar

Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients

Su-Lin Yu 1 , Hong Deng 1 , * , Xin-Hua Li 1 , Ya-Xin Huang 1 , Dong-Ying Xie 1 and Zhi-Liang Gao 1
Authors Information
1 Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Article information
  • Hepatitis Monthly: January 01, 2016, 16 (1); e34483
  • Published Online: January 30, 2016
  • Article Type: Research Article
  • Received: November 12, 2015
  • Revised: December 18, 2015
  • Accepted: January 1, 2016
  • DOI: 10.5812/hepatmon.34483

To Cite: Yu S, Deng H, Li X, Huang Y, Xie D, et al. Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients, Hepat Mon. 2016 ; 16(1):e34483. doi: 10.5812/hepatmon.34483.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 2. Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, Takahashi S, et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology. 2009; 136(2): 652-662. e3
  • 3. Chisari FV. Viruses, Immunity, and Cancer: Lessons from Hepatitis B. Am J Pathol. 2000; 156(4): 1117-32[DOI]
  • 4. Xibing G, Xiaojuan Y, Zhonghua L, Juanhua W. Alteration in cellular immunity after chronic hepatitis B deteriorated into severe hepatitis and its significance. Hepat Mon. 2011; 11(10): 810-5[DOI][PubMed]
  • 5. Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012; 6(3): 531-61[DOI][PubMed]
  • 6. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008; 9(8): 839-45[DOI][PubMed]
  • 7. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010; 33(4): 607-19[DOI][PubMed]
  • 8. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of Tissue-Specific MicroRNAs from Mouse. Cur Biol. 2002; 12(9): 735-9[DOI]
  • 9. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007; 316(5824): 608-11[DOI][PubMed]
  • 10. van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T, et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer. 2003; 37(1): 20-8[DOI][PubMed]
  • 11. Haasch D, Chen YW, Reilly RM, Chiou XG, Koterski S, Smith M, et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene,. BIC. 2002; 217(1-2): 78-86[DOI]
  • 12. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007; 104(5): 1604-9[DOI][PubMed]
  • 13. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A. 2009; 106(8): 2735-40[DOI][PubMed]
  • 14. Sullivan RP, Fogel LA, Leong JW, Schneider SE, Wong R, Romee R, et al. MicroRNA-155 Tunes Both the Threshold and Extent of NK Cell Activation via Targeting of Multiple Signaling Pathways. The Journal of Immunology. 2013; 191(12): 5904-13[DOI]
  • 15. Gracias DT, Stelekati E, Hope JL, Boesteanu AC, Doering TA, Norton J, et al. The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling. Nature Immunology. 2013; 14(6): 593-602[DOI]
  • 16. Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, Marmiroli N, et al. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. Blood. 2012; 119(26): 6259-67[DOI][PubMed]
  • 17. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology. 2012; 56(5): 1631-40[DOI][PubMed]
  • 18. Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D, et al. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med. 2012; 10: 151[DOI][PubMed]
  • 19. Riad SE, El-Ekiaby N, Mekky RY, Ahmed R, El Din MA, El-Sayed M, et al. Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection. Biomed Rep. 2015; 3(1): 93-7[DOI][PubMed]
  • 20. Su C, Hou Z, Zhang C, Tian Z, Zhang J. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J. 2011; 8: 354[DOI][PubMed]
  • 21. Sarkar N, Panigrahi R, Pal A, Biswas A, Singh SP, Kar SK, et al. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-βin hepatocytes. Journal of Viral Hepatitis. 2015; 22(10): 817-27[DOI]
  • 22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4): 402-8[DOI][PubMed]
  • 23. Wu ZQ, Tan L, Liu T, Gao ZL, Ke WM. Evaluation of changes of serum hepatitis B surface antigen from a different perspective. World J Gastroenterol. 2015; 21(9): 2739-45[DOI][PubMed]
  • 24. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009; 136(1): 26-36[DOI][PubMed]
  • 25. Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol. 2013; 14(3): 205-10[DOI][PubMed]
  • 26. Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013; 10(9): 542-52[DOI][PubMed]
  • 27. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007; 27(6): 847-59[DOI][PubMed]
  • 28. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007; 316(5824): 604-8[DOI][PubMed]
  • 29. Yu D. MicroRNAs in Tfh cells: micromanaging inflammaging. Immunity. 2014; 41(4): 509-11[DOI][PubMed]
  • 30. Zawislak CL, Beaulieu AM, Loeb GB, Karo J, Canner D, Bezman NA, et al. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc Natl Acad Sci U S A. 2013; 110(17): 6967-72[DOI][PubMed]
  • 31. Tang G, Shen X, Lv K, Wu Y, Bi J, Shen Q. Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma. Med Sci Monit. 2015; 21: 617-24[DOI][PubMed]
  • 32. Jiang M, Broering R, Trippler M, Wu J, Zhang E, Zhang X, et al. MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver. J Viral Hepat. 2014; 21(2): 99-110[DOI][PubMed]
  • 33. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol. 2010; 84(22): 11670-8[DOI][PubMed]
  • 34. Swaminathan G, Rossi F, Sierra LJ, Gupta A, Navas-Martin S, Martin-Garcia J. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog. 2012; 8(9)[DOI][PubMed]
  • 35. Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol. 2003; 18(3): 246-52[PubMed]
  • 36. Vigorito E, Kohlhaas S, Lu D, Leyland R. miR-155: an ancient regulator of the immune system. Immunol Rev. 2013; 253(1): 146-57[DOI][PubMed]
  • 37. Cieslar-Pobuda A, Wiechec E. Research on liver regeneration as an answer to the shortage of donors for liver transplantation. Hepatol Res. 2014; 44(9): 944-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments